Model
Edge
Regeneron Pharmaceuticals, Inc.
0001585160
Filing Type
144
Filing Date
2/6/2024
Updated
2/7/24, 10:59 AM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities